Botulinum Toxin Injections
J15
20 active Medicare policies list L74.52, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
7 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of L74.52 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Hyperhidrosis | Jul 18, 2023 | Covered |
| Iontophoresis | Apr 26, 2023 | Covered |
| Skin and Soft Tissue Substitutes | Feb 9, 2024 | Covered |
| Thoracoscopic Sympathectomy | May 8, 2023 | Covered |
| Policy | Effective |
|---|
J5
J8 · Effective Feb 22, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
| Status of L74.52 |
|---|
| Iontophoresis | Jan 6, 2026 | Covered |
|---|---|---|
| Surgical Treatment of Hyperhidrosis | Jan 6, 2026 | Covered |